Tetraphase Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TTPH Nasdaq 8731 https://www.tphase.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tetraphase Pharmaceuticals Inc

Analysts’ Ratings for Sarepta Therapeutics and Peers in April - Apr 20th, 2018 3:59 pm
Tetraphase Pharmaceuticals’ Cash Flow and Price Performance - Apr 19th, 2018 5:33 am
Tetraphase Pharmaceuticals to Present Data at the 38th Annual Meeting of the Surgical Infection Society - Apr 19th, 2018 5:00 am
Exploring Tetraphase Pharmaceuticals’ Financial Performance - Apr 18th, 2018 1:32 pm
A Look at Tetraphase Pharmaceuticals’ Target Market - Apr 18th, 2018 1:32 pm
How Analysts View Tetraphase Pharmaceuticals in April 2018 - Apr 18th, 2018 1:32 pm
Blog Exposure - Tetraphase Pharma Announced Data Presentations from IGNITE4 Study at 28th European Congress of Clinical Microbiology and Infectious Diseases - Apr 16th, 2018 5:20 am
Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases - Apr 12th, 2018 5:00 am
Top High Growth NasdaqCM Stocks This Month - Apr 11th, 2018 10:02 am
Tetraphase Pharmaceuticals to Present at H.C. Wainwright Annual Global Life Sciences Conference - Apr 2nd, 2018 5:00 am
New Research: Key Drivers of Growth for First Defiance Financial, Tetraphase Pharmaceuticals, LRAD, LPL Financial, Hubbell, and Castlight Health, inc. — Factors of Influence, Major Initiatives and Sustained Production - Mar 21st, 2018 6:15 am
Tetraphase Pharmaceuticals to Present at 17th Annual Needham Healthcare Conference - Mar 20th, 2018 2:01 pm
Is It The Right Time To Buy Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)? - Mar 7th, 2018 8:35 am
Tetraphase reports 4Q loss - Mar 6th, 2018 4:09 pm
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results, Highlights Achievements and Key 2018 Milestones - Mar 6th, 2018 2:40 pm
Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer - Mar 1st, 2018 2:01 pm
Priority Review For Tetraphase's Eravacycline A 'Key Positive,' Analyst Says - Feb 28th, 2018 12:48 pm
Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI) - Feb 27th, 2018 6:00 am
Benzinga Pro's Stocks To Watch Today - Feb 21st, 2018 8:23 am
Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines for Eravacycline in China - Feb 20th, 2018 2:01 pm